Medication management of chronic heart failure in older adults.

Item

http://www.wikidata.org/entity/Q38126374

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Medication management of chronic heart failure in older adults.

@en

type

Item

label

Medication management of chronic heart failure in older adults.

@en

prefLabel

Medication management of chronic heart failure in older adults.

@en

P1476

Medication management of chronic heart failure in older adults.

@en

P2093

Kannayiram Alagiakrishnan

http://www.w3.org/2001/XMLSchema#string

Linda G Jones

http://www.w3.org/2001/XMLSchema#string

Wilbert S Aronow

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial I

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

P2888

s40266-013-0105-9

P304

765-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40266-013-0105-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maciej Banach

Ali Ahmed

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255177731

http://www.w3.org/2001/XMLSchema#string

P698

23912673

http://www.w3.org/2001/XMLSchema#string

P921

heart failure